Actively Recruiting
Fear of Recurrence and Stopping Immunotherapy
Led by University of Pittsburgh · Updated on 2025-12-05
100
Participants Needed
1
Research Sites
386 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
CONDITIONS
Official Title
Fear of Recurrence and Stopping Immunotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 21 years and older
- Fluent in English
- Diagnosis of cancer and history of treatment with immunotherapy
You will not qualify if you...
- Active suicidal ideation, delusions or hallucinations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UPMC Hillman Cancer Centers
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
Research Team
J
Jennifer L Steel, Ph.D.
CONTACT
J
Jason Luke, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here